Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 2006 Jan 23;203(1):251. doi: 10.1084/jem.20050595010606c

Correction

Qiang Pan-Hammarström, Aleksi Lähdesmäki, Yaofeng Zhao, Likun Du, Zhihui Zhao, Sicheng Wen, Victor L Ruiz-Perez, Deborah K Dunn-Walters, Judith A Goodship, Lennart Hammarström
PMCID: PMC2118083

Vol. 203, No. 1, January 23, 2006. Pages 99-100.

All data in the bottom row of Table II should have been shifted one column to the right. The corrected table appears below.

Table II.

Mutations in VH3-23-Cγ transcripts from PBL from ATRD patients and controlsa

Clones
Mutations in V region
Clustering ratio
R/S
Age (yr) All Distinct Unmutated Total % bp CDR/FRb CDRs FRs
ATRD patients
    ATRD1 25 15 13 0 302 8.6 0.73 3.4 1.8
    ATRD2 13 15 14 2 258 6.8 0.73 3.7 1.7
    ATRD3 15 6 6 0 194 11.9 0.62 3.9 2.0
    Total 36 33 2 754 8.4 0.70 3.6 1.8
Controls
    C1 14 12 11 1 100 3.4 1.22 5.9 1.5
    C2 adult 11 11 0 275 9.3 0.73 4.5 1.7
    C3 28 6 6 0 147 9.0 0.69 5.7 2.0
    C4 24 8 8 0 178 8.2 0.51 14.0 2.2
    C5 30 4 4 0 49 4.5 0.53 c 1.1
    Total 41 40 1 749 6.9 0.70 6.2 1.8
a

Total RNA was prepared from PBL from all the patients and controls, except for donor C2; buffycoat was obtained and CD27 positive B cells were used.

b

FR, framework region.

c

Too few mutations to give a reliable ratio.


Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES